Caveolin 3-dependent loss of t-tubular ICa during hypertrophy and heart failure in mice

Simon M Bryant1, Cherrie H T Kong1, Judy J Watson1

  • 1School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.

Experimental Physiology
|February 24, 2018
PubMed

Insights

Pathological heart failure involves loss of t-tubular L-type Ca2+ current (ICa). This loss is linked to decreased caveolin-3 (Cav3) and worsens with disease severity, impairing cardiac function.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cellular Physiology

Background:

  • Redistribution of L-type Ca2+ current (ICa) from t-tubules to surface membrane occurs in heart failure.
  • The mechanism and severity-dependence of this ICa redistribution are unclear.

Purpose of the Study:

  • Investigate ICa redistribution in response to pressure overload in mice.
  • Determine the underlying mechanism and its relation to disease severity.

Main Methods:

  • Transverse aortic constriction (TAC) in mice to induce pressure overload.
  • Measurement of ICa and Ca2+ transients in isolated myocytes.
  • Assessment of caveolin-3 (Cav3), junctophilin-2 (Jph2), and bridging integrator-1 (Bin1) expression.

Main Results:

  • Graded loss of t-tubular ICa density with increasing TAC severity.
  • Decreased expression of Jph2 and Cav3 correlated with ICa loss.
  • Disruption of Cav3 binding impaired ICa in control but not TAC myocytes.

Conclusions:

  • Pathological loss of t-tubular ICa is linked to decreased Cav3 expression and function.
  • This loss contributes to impaired excitation-contraction coupling and cardiac dysfunction.
  • Cav3-dependent stimulation is crucial for maintaining t-tubular ICa.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
399
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
363